Search Results - "Graff, Alan"

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults by Pool, James L., MD, Glazer, Robert, MD, Weinberger, Myron, MD, Alvarado, Roxanne, MS, Huang, Jie, PhD, Graff, Alan, MD

“…Abstract Background: One third of patients treated for hypertension attain adequate blood pressure (BP) control, and multidrug regimens are often required…”
Get full text

The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study by Neutel, Joel M., Bestermann, William H., Dyess, Eric M., Graff, Alan, Kursun, Attila, Sutradhar, Santosh, Yunis, Carla

“…Poor control of hypertension or dyslipidemia may at least in part be due to these risk factors being treated in isolation. The Caduet in Untreated Subjects…”
Get full text

Geometry of enolization using a bifunctional cyclodextrin-based catalyst by Breslow, Ronald, Graff, Alan

Get full text

A Titrate‐to‐Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed‐Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide by Weir, Matthew R., Hsueh, Willa A., Nesbitt, Shawna D., Littlejohn, Thomas J., Graff, Alan, Shojaee, Ali, Waverczak, William F., Qian, Chunlin, Jones, Christopher J., Neutel, Joel M.

“…In the prospective, open‐label, titrate‐to‐goal Blood Pressure Control in All Subgroups With Hypertension (BP‐CRUSH) study, 999 patients with hypertension…”
Get full text

Efficacy/Safety of Olmesartan Medoxomil versus Losartan Potassium in Patients by Stage 1 or 2 Hypertension by Flack, John M., Graff, Alan, Li, Wei, Chavanu, Kathleen J.

“…An exploratory subgroup analysis of a prospective, randomized, double-blind, forced-titration study comparing the efficacy and safety of once-daily olmesartan…”
Get full text

A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide: Switching Patients on Monotherapy to AML/OM by Weir, Matthew R., Hsueh, Willa A., Nesbitt, Shawna D., Littlejohn, Thomas J., Graff, Alan, Shojaee, Ali, Waverczak, William F., Qian, Chunlin, Jones, Christopher J., Neutel, Joel M.

Get full text

Efficacy of a Once‐Daily Formulation of Carvedilol for the Treatment of Hypertension by Weber, Michael A., Bakris, George L., C, Elizabeth A., Iyengar, Malini, Fleck, Richard, Sica, Domenic A.

“…β‐Blockers with pharmacologic effects that differ from conventional agents might add to antihypertensive treatment options. This study evaluated a new…”
Get full text

Target Standing Under Section 16 of the Clayton Act: When Your Antitrust Injury Hurts, Standing Can Be a Problem by Graff, Glenn Alan

Get full text